TCI Peptide Therapeutics

BioTech/Drugs - Columbia, MO, US

TCI Peptide Therapeutics Employees
LeAnn Kuhlmann

Chief Commercial Officer

Contact LeAnn Kuhlmann

Leann Qi

Chief Commercialization Officer

Contact Leann Qi

Contact All TCI Peptide Therapeutics Employees
TCI Peptide Therapeutics Details

Endevica Bio was formed in 2009 to create best in class peptide drug candidates with better safety and efficacy properties than other drugs in the same class. Endevica Bio's lead drug candidate is a peptide therapeutic for treating cachexia due to cancer and other chronic conditions. An IND is anticipated by the end of 2021 with a Phase 1 Clinical trial in 1st quarter 2022.

TCI Peptide Therapeutics logo, TCI Peptide Therapeutics contact details
Employees: 5 - 9
HQ: 573-881-5080
Location: Columbia, MO, US
Revenue: Not Available
Peptides Drug Design Drug Delivery Cachexia Animal Health Drug Development
TCI Peptide Therapeutics Technologies
Email Providers

Outlook

Load Balancers

Apache

CMS

WordPress.org

Fonts

Google Font API

Other

Mobile Friendly

View All Technologies Used At TCI Peptide Therapeutics

Contacting TCI Peptide Therapeutics: Connect with Executives and Employees

Get in Touch with TCI Peptide Therapeutics Executives and Employees

Connecting with TCI Peptide Therapeutics's Executives and Workforce

Accessing Contact Information for TCI Peptide Therapeutics Executives

Connecting with TCI Peptide Therapeutics: Reach Out to Their Team

Discover How to Contact TCI Peptide Therapeutics Executives and Staff

Looking to connect with TCI Peptide Therapeutics executives or employees?

Seeking to Get in Touch with TCI Peptide Therapeutics Executives or Staff?

Want to Reach Out to TCI Peptide Therapeutics Executives or Team Members?

In Search of Contact Details for TCI Peptide Therapeutics Professionals?

Connecting with TCI Peptide Therapeutics: Contacting Executives and Staff

Browse companies
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z